Bevacizumab versus anti–epidermal growth factor receptor in first-line metastatic colorectal cancer. A meta-analysis: The last building block?

Publication date: December 2016
Source:European Journal of Cancer, Volume 69
Author(s): Michel Ducreux, Jean-Pierre Pignon




http://rss.sciencedirect.com/action/redirectFile?&zone=main&currentActivity=feed&usageType=outward&url=http%3A%2F%2Fwww.sciencedirect.com%2Fscience%3F_ob%3DGatewayURL%26_origin%3DIRSSSEARCH%26_method%3DcitationSearch%26_piikey%3DS0959804916324674%26_version%3D1%26md5%3Dde8846be7fcbc1d2ffcf2627506e463d